Toxicodendron Pubescens Leaf NDC 53499-2991

NDC codes

FDA NDC Directory

Product NDC (as listed)53499-2991Labeler and product segments. Claims need a package NDC.

Product NDC at billing width53499-2991Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
53499-2991-4	53499299104	1 BOTTLE, DROPPER in 1 BOX (53499-2991-4) / 30 mL in 1 BOTTLE, DROPPERMarketed from Mar 2, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Toxicodendron Pubescens Leaf
Generic name (nonproprietary): toxicodendron pubescens leaf
Active ingredients: Toxicodendron pubescens leaf — 4 [hp_X]/30mL
Dosage form: Liquid
Route: Oral
Labeler: Schwabe North America, Inc
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Mar 2, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 53499-2991_2003ae19-1634-4726-a118-37128dd89a05SPL ID 2003ae19-1634-4726-a118-37128dd89a05SPL set ID 26e656a6-0549-4536-bc33-cc9b22cfce6fUNII 6IO182RP7AUPC 0308079009901

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N453499299104 followed by a unit qualifier and the quantity

Package 53499-2991-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 24, 2025.

Indications (excerpt from the label)

Indications & Usage Temporarily relieves symptoms of contact dermatitis associated with posion ivy, oak, and sumac, including: itching, red or burning skin rashes, blisters with oozing or crusting, skin irritation, swelling.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)